Amlodipine Besylate (Afcca25d 0e19 4800 A55d 1714067a4400 01)
Amlodipine Besylate Tablet
Product Images NDC 50090-5355
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 50090-5355). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine versus Placebo)
This is a description of a Kaplan-Meier analysis comparing the composite clinical outcomes of Amlodipine versus Placebo. The results indicate a statistically significant difference with a p-value of 0.003. The Hazard Ratio is 0.691 with a 95% confidence interval ranging from 0.54 to 0.88. The analysis is shown graphically in Figure 1 over a period of time in months.*
Figure 2 (Effects on Primary Endpoint of Amlodipine versus Placebo across Sub-Groups)
This is a statistical breakdown of clinical trial data comparing the effects of Amlodipine versus placebo in a sample of 1318 patients. The information includes gender distribution, baseline blood pressure levels, vessel disease status, and stent placement among the participants. The hazard ratio with a 95% confidence interval is also provided.*
Label Image (Lbl500905355)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
